A citation-based method for searching scientific literature

Saliha Majdoul, Alex A Compton. Nat Rev Immunol 2021
Times Cited: 3







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cytokine Storms: Understanding COVID-19.
Nilam Mangalmurti, Christopher A Hunter. Immunity 2020
221
66

LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
Xuesen Zhao, Shuangli Zheng, Danying Chen, Mei Zheng, Xinglin Li, Guoli Li, Hanxin Lin, Jinhong Chang, Hui Zeng, Ju-Tao Guo. J Virol 2020
33
66

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
66

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
Daniel Blanco-Melo, Benjamin E Nilsson-Payant, Wen-Chun Liu, Skyler Uhl, Daisy Hoagland, Rasmus Møller, Tristan X Jordan, Kohei Oishi, Maryline Panis, David Sachs,[...]. Cell 2020
66

Mechanisms of Antiviral Immune Evasion of SARS-CoV-2.
Daniel K Beyer, Adriana Forero. J Mol Biol 2021
3
66

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
Jérôme Hadjadj, Nader Yatim, Laura Barnabei, Aurélien Corneau, Jeremy Boussier, Nikaïa Smith, Hélène Péré, Bruno Charbit, Vincent Bondet, Camille Chenevier-Gobeaux,[...]. Science 2020
66

Activation and evasion of type I interferon responses by SARS-CoV-2.
Xiaobo Lei, Xiaojing Dong, Ruiyi Ma, Wenjing Wang, Xia Xiao, Zhongqin Tian, Conghui Wang, Ying Wang, Li Li, Lili Ren,[...]. Nat Commun 2020
302
66

Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism.
Jung-Eun Park, Kun Li, Arlene Barlan, Anthony R Fehr, Stanley Perlman, Paul B McCray, Tom Gallagher. Proc Natl Acad Sci U S A 2016
166
33

β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway.
Sourish Ghosh, Teegan A Dellibovi-Ragheb, Adeline Kerviel, Eowyn Pak, Qi Qiu, Matthew Fisher, Peter M Takvorian, Christopher Bleck, Victor W Hsu, Anthony R Fehr,[...]. Cell 2020
124
33

Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein.
Kathryn Schornberg, Shutoku Matsuyama, Kirsten Kabsch, Sue Delos, Amy Bouton, Judith White. J Virol 2006
310
33

Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis.
Jason Kindrachuk, Britini Ork, Brit J Hart, Steven Mazur, Michael R Holbrook, Matthew B Frieman, Dawn Traynor, Reed F Johnson, Julie Dyall, Jens H Kuhn,[...]. Antimicrob Agents Chemother 2015
207
33


The C-terminal sequence of IFITM1 regulates its anti-HIV-1 activity.
Rui Jia, Shilei Ding, Qinghua Pan, Shan-Lu Liu, Wentao Qiao, Chen Liang. PLoS One 2015
23
33

The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro.
Tomer M Yaron, Brook E Heaton, Tyler M Levy, Jared L Johnson, Tristan X Jordan, Benjamin M Cohen, Alexander Kerelsky, Ting-Yu Lin, Katarina M Liberatore, Danielle K Bulaon,[...]. bioRxiv 2020
17
33

mTOR: from growth signal integration to cancer, diabetes and ageing.
Roberto Zoncu, Alejo Efeyan, David M Sabatini. Nat Rev Mol Cell Biol 2011
33

Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model.
Ching-Tai Huang, Chen-Yiu Hung, Tse-Ching Chen, Chun-Yen Lin, Yung-Chang Lin, Chia-Shiang Chang, Yueh-Chia He, Yu-Lin Huang, Avijit Dutta. Sci Rep 2017
12
33

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
David E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, Jiewei Xu, Kirsten Obernier, Kris M White, Matthew J O'Meara, Veronica V Rezelj, Jeffrey Z Guo, Danielle L Swaney,[...]. Nature 2020
33

Chasing the elusive mammalian microautophagy.
Laura Santambrogio, Ana M Cuervo. Autophagy 2011
45
33

Rapalogs and mTOR inhibitors as anti-aging therapeutics.
Dudley W Lamming, Lan Ye, David M Sabatini, Joseph A Baur. J Clin Invest 2013
297
33

Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.
William M Schneider, Joseph M Luna, H-Heinrich Hoffmann, Francisco J Sánchez-Rivera, Andrew A Leal, Alison W Ashbrook, Jérémie Le Pen, Inna Ricardo-Lax, Eleftherios Michailidis, Avery Peace,[...]. Cell 2021
101
33

Sirolimus alters lung pathology and viral load following influenza A virus infection.
Ahmed R Alsuwaidi, Junu A George, Saeeda Almarzooqi, Stacey M Hartwig, Steven M Varga, Abdul-Kader Souid. Respir Res 2017
14
33

IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Alex A Compton, Timothée Bruel, Françoise Porrot, Adeline Mallet, Martin Sachse, Marine Euvrard, Chen Liang, Nicoletta Casartelli, Olivier Schwartz. Cell Host Microbe 2014
118
33

Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells.
Mahmood Yaseen Hachim, Saba Al Heialy, Ibrahim Yaseen Hachim, Rabih Halwani, Abiola C Senok, Azzam A Maghazachi, Qutayba Hamid. Front Immunol 2020
22
33

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
Jin Wei, Mia Madel Alfajaro, Peter C DeWeirdt, Ruth E Hanna, William J Lu-Culligan, Wesley L Cai, Madison S Strine, Shang-Min Zhang, Vincent R Graziano, Cameron O Schmitz,[...]. Cell 2021
143
33

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.
Yadi Zhou, Yuan Hou, Jiayu Shen, Yin Huang, William Martin, Feixiong Cheng. Cell Discov 2020
335
33

Drug repurposing against COVID-19: focus on anticancer agents.
Gennaro Ciliberto, Rita Mancini, Marco G Paggi. J Exp Clin Cancer Res 2020
26
33

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.
Yadi Zhou, Yuan Hou, Jiayu Shen, Yin Huang, William Martin, Feixiong Cheng. Cell Discov 2020
677
33

A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB.
Carmine Settembre, Roberto Zoncu, Diego L Medina, Francesco Vetrini, Serkan Erdin, SerpilUckac Erdin, Tuong Huynh, Mathieu Ferron, Gerard Karsenty, Michel C Vellard,[...]. EMBO J 2012
33


The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway.
Nicholas J Buchkovich, Yongjun Yu, Carisa A Zampieri, James C Alwine. Nat Rev Microbiol 2008
177
33

Interferon induction of IFITM proteins promotes infection by human coronavirus OC43.
Xuesen Zhao, Fang Guo, Fei Liu, Andrea Cuconati, Jinhong Chang, Timothy M Block, Ju-Tao Guo. Proc Natl Acad Sci U S A 2014
100
33


Interferon-Induced Transmembrane Protein 3 Blocks Fusion of Diverse Enveloped Viruses by Altering Mechanical Properties of Cell Membranes.
Xiangyang Guo, Jan Steinkühler, Mariana Marin, Xiang Li, Wuyuan Lu, Rumiana Dimova, Gregory B Melikyan. ACS Nano 2021
10
33

Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy.
Giulia Giordano, Franco Blanchini, Raffaele Bruno, Patrizio Colaneri, Alessandro Di Filippo, Angela Di Matteo, Marta Colaneri. Nat Med 2020
450
33


IFITMs restrict the replication of multiple pathogenic viruses.
Jill M Perreira, Christopher R Chin, Eric M Feeley, Abraham L Brass. J Mol Biol 2013
145
33


Dose translation from animal to human studies revisited.
Shannon Reagan-Shaw, Minakshi Nihal, Nihal Ahmad. FASEB J 2008
33

Homology-guided identification of a conserved motif linking the antiviral functions of IFITM3 to its oligomeric state.
Kazi Rahman, Charles A Coomer, Saliha Majdoul, Selena Y Ding, Sergi Padilla-Parra, Alex A Compton. Elife 2020
18
33

A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.
Sarah R Leist, Kenneth H Dinnon, Alexandra Schäfer, Longping V Tse, Kenichi Okuda, Yixuan J Hou, Ande West, Caitlin E Edwards, Wes Sanders, Ethan J Fritch,[...]. Cell 2020
133
33

Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.
Ji Hoon Baang, Christopher Smith, Carmen Mirabelli, Andrew L Valesano, David M Manthei, Michael A Bachman, Christiane E Wobus, Michael Adams, Laraine Washer, Emily T Martin,[...]. J Infect Dis 2021
83
33

mTOR signaling in growth control and disease.
Mathieu Laplante, David M Sabatini. Cell 2012
33

Viral and host factors related to the clinical outcome of COVID-19.
Xiaonan Zhang, Yun Tan, Yun Ling, Gang Lu, Feng Liu, Zhigang Yi, Xiaofang Jia, Min Wu, Bisheng Shi, Shuibao Xu,[...]. Nature 2020
348
33

Rapamycin passes the torch: a new generation of mTOR inhibitors.
Don Benjamin, Marco Colombi, Christoph Moroni, Michael N Hall. Nat Rev Drug Discov 2011
605
33

mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3.
Guoli Shi, Stosh Ozog, Bruce E Torbett, Alex A Compton. Proc Natl Acad Sci U S A 2018
32
33


IFITM proteins restrict viral membrane hemifusion.
Kun Li, Ruben M Markosyan, Yi-Min Zheng, Ottavia Golfetto, Brittani Bungart, Minghua Li, Shilei Ding, Yuxian He, Chen Liang, James C Lee,[...]. PLoS Pathog 2013
214
33


Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
Carly G K Ziegler, Vincent N Miao, Anna H Owings, Andrew W Navia, Ying Tang, Joshua D Bromley, Peter Lotfy, Meredith Sloan, Hannah Laird, Haley B Williams,[...]. bioRxiv 2021
9
33

Functional Landscape of SARS-CoV-2 Cellular Restriction.
Laura Martin-Sancho, Mary K Lewinski, Lars Pache, Charlotte A Stoneham, Xin Yin, Dexter Pratt, Christopher Churas, Sara B Rosenthal, Sophie Liu, Paul D De Jesus,[...]. bioRxiv 2020
13
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.